Advanced search
Publication Cover
Pharmaceutical Biology Volume 59, 2021 - Issue 1
Submit an article Journal homepage
1,710
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Cryptotanshinone enhances the efficacy of Bcr-Abl tyrosine kinase inhibitors via inhibiting STAT3 and eIF4E signalling pathways in chronic myeloid leukaemia

Rubin Chenga School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, ChinaView further author information
,
Yilan Huanga School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, ChinaView further author information
,
Yun Fanga School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, ChinaView further author information
,
Qirui Wanga School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, ChinaView further author information
,
Meixiu Yana School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, ChinaView further author information
&
Yuqing Geb The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, ChinaCorrespondence[email protected]
View further author information
Pages 891-901 | Received 17 Oct 2020, Accepted 12 Jun 2021, Published online: 02 Jul 2021

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.